Fingertips Practice Dashboard (PCN Comparison)
Selected practice
The Woodberry Practice
F85020
PCN: ENFIELD SOUTH WEST PCN
This view compares the selected practice with its PCN average using the same indicator, time period, and visible breakdown where available.
Indicators shown
5
Themes shown
1
Matched PCN rows
5
Average gap
3.32
Top opportunities vs PCN
% reporting cancer in the last 5 years
Screening | 2024
1.87
+0.10
Patients with cancer who had an opportunity for a discussion within 3 months of diagnosis (denominator incl. PCAs)
Screening | 2024/25
94.74
+0.34
Patients with cancer reviewed within 12 months of diagnosis (denominator incl. PCAs)
Screening | 2024/25
100.00
+1.34
Women (50-64 yrs), with a record of cervical screening in the last 5.5 yrs (denominator incl. PCAs)
Screening | 2024/25
79.07
+5.30
Women (25-49 yrs), with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)
Screening | 2024/25
72.95
+9.53
Top strengths vs PCN
Women (25-49 yrs), with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)
Screening | 2024/25
72.95
+9.53
Women (50-64 yrs), with a record of cervical screening in the last 5.5 yrs (denominator incl. PCAs)
Screening | 2024/25
79.07
+5.30
Patients with cancer reviewed within 12 months of diagnosis (denominator incl. PCAs)
Screening | 2024/25
100.00
+1.34
Patients with cancer who had an opportunity for a discussion within 3 months of diagnosis (denominator incl. PCAs)
Screening | 2024/25
94.74
+0.34
% reporting cancer in the last 5 years
Screening | 2024
1.87
+0.10
72.95
Women (25-49 yrs), with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs)
2024/25 | %
PCN: 63.42
Gap: +9.53
79.07
Women (50-64 yrs), with a record of cervical screening in the last 5.5 yrs (denominator incl. PCAs)
2024/25 | %
PCN: 73.77
Gap: +5.30
PCN comparison bar chart
Comparison table
| Indicator | Theme | Breakdown | Time period | Practice | PCN | Gap | Unit |
|---|---|---|---|---|---|---|---|
| % reporting cancer in the last 5 years | Screening | 16+ yrs | 2024 | 1.87 | 1.77 | +0.10 | % |
| Patients with cancer reviewed within 12 months of diagnosis (denominator incl. PCAs) | Screening | All ages | 2024/25 | 100.00 | 98.66 | +1.34 | % |
| Patients with cancer who had an opportunity for a discussion within 3 months of diagnosis (denominator incl. PCAs) | Screening | All ages | 2024/25 | 94.74 | 94.40 | +0.34 | % |
| Women (25-49 yrs), with a record of cervical screening in the last 3.5 yrs (denominator incl. PCAs) | Screening | Female | 25-49 yrs | 2024/25 | 72.95 | 63.42 | +9.53 | % |
| Women (50-64 yrs), with a record of cervical screening in the last 5.5 yrs (denominator incl. PCAs) | Screening | Female | 50-64 yrs | 2024/25 | 79.07 | 73.77 | +5.30 | % |